We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Finger Scanner for Malaria to Be Developed

By LabMedica International staff writers
Posted on 13 May 2010
An optomagnetic finger scanner is being developed for the diagnosis of malaria.

The noninvasive finger scanner will detect the presence of malarial hemozoin crystals in infected individuals. More...
Hemozoin is the iron-containing pigment, which accumulates as cytoplasmic granules in malaria parasites and is a breakdown product of hemoglobin.

Light-emitting diodes, magnets, and electronic components available to do-it-yourself hobbyists will be used for constructing the instrument. In contrast to the test under development, current diagnosis of malaria is performed using invasive blood tests requiring sizable equipment.

On May 11, 2010, the DNA Medicine Institute (Cambridge, MA, USA) announced that it received a US $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation (Seattle, WA, USA) to develop the optomagnetic finger scanner. The project will be conducted by the DNA Medicine Institute's Eugene Y. Chan, M.D.

"I am pleased to have the opportunity to pursue an idea that pushes the envelope of malaria diagnosis. Malaria is a deadly disease that afflicts up to 500 million people each year. Millions die from it, including many young children in developing countries. My group is developing a tiny device that scans a finger, without any blood [sample], to allow anyone, anytime, and anywhere to check for malaria infection," said Dr. Chan.

Related Links:
DNA Medicine Institute
Bill & Melinda Gates Foundation


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.